
Codexis CDXS
$ 2.67
-5.32%
Annual report 2025
added 03-11-2026
Codexis DIO Ratio 2011-2026 | CDXS
Annual DIO Ratio Codexis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.7 | 50.2 | 67.2 | 15.3 | 17.5 | 17.7 | 8.66 | 17 | 26.4 | 30.9 | 55 | 52.4 | 37.3 | 15.5 | 39.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.7 | 8.66 | 34.7 |
Quarterly DIO Ratio Codexis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.8 | 81 | 59.8 | - | 45.8 | 61.6 | 48.2 | - | 88.4 | 58.1 | 40.6 | - | 7.57 | 6.32 | 14.6 | - | 14.4 | 22.3 | 21.6 | - | 24.1 | 51.8 | 24 | - | 6.68 | 12.2 | 9.97 | - | 14.2 | 20.6 | 19.4 | - | 23.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 88.4 | 6.32 | 33.9 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Cerus Corporation
CERS
|
213 | $ 2.72 | 33.99 % | $ 518 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
295 | $ 21.95 | -2.23 % | $ 3.64 B | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Caladrius Biosciences
CLBS
|
35.8 | - | -16.75 % | $ 25.8 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.04 K | - | - | $ 2.18 B | ||
|
Dynavax Technologies Corporation
DVAX
|
455 | - | - | $ 2.02 B | ||
|
Edesa Biotech
EDSA
|
184 | $ 17.59 | -3.75 % | $ 56.2 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
33.5 K | - | -9.21 % | $ 2.55 M |